RAS/Mitogen-Activated Protein Kinase Signaling Pathway in Testicular Germ Cell Tumors
Open Access
Abstract
Germ cell tumors (GCTs) are relatively rare tumors. However, they are the most diagnosed malignancies occurring in the testis among men aged between 15 and 40 years. Despite high aneuploidy and a paucity of somatic mutations, several genomic and transcriptomic assays have identified a few significantly mutated somatic genes, primarily KIT and K-RAS. The receptor Tyrosine Kinase (RTK) pathway and the downstream related Mitogen-Activated Protein Kinase (MAPK) cascades are crucial signal transduction pathways that preside over various cellular processes, including proliferation, differentiation, apoptosis, and responses to stressors. They are well described in solid malignancies, where many of the involved factors are used as prognostic molecular markers or targets for precision therapy. This narrative review focused, in the first part, on PGCs’ survival/proliferation and differentiation and on the genetic and epigenetic factors involved in the pathogenesis of testicular germ cell tumors (TGCTs) and, in the second part, on the most recent investigations about the KIT-RAS pathway in TGCTs and in other cancers, highlighting the efforts that are being made to identify targetable markers for precision medicine approaches.Keywords
All Related Versions
Funding Information
- The Ministero dell’Università e della Ricerca (2020XMLP45_004)
This publication has 111 references indexed in Scilit:
- Endocannabinoid system and epigenetics in spermatogenesis and testicular cancer2023
- Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumoursCancer Genetics, 2020
- Regulation of Kit Expression in Early Mouse Embryos and ES CellsStem Cells, 2018
- MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK ActivationCancer Cell, 2018
- Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumorsCancer Letters, 2016
- The MAPK pathway across different malignancies: A new perspectiveCancer, 2014
- Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumorsGenes, Chromosomes and Cancer, 2011
- Mutant p53 gain of function is interwoven into the hallmarks of cancerThe Journal of Pathology, 2011
- Mutations of BRAF and RAS are rare events in germ cell tumoursInternational Journal of Cancer, 2004
- Derivation of pluripotential embryonic stem cells from murine primordial germ cells in cultureCell, 1992